Coronavirus Update: Pfizer And BioNTech Kick Off COVID-19 Trial

Dose-Escalation Stage To Enrol Up To 360 Subjects

 
• By Scrip Team

The US behemoth and its German partner have said that if their mRNA vaccine proves to be safe and effective, it could  be ready for US distribution by the end of the year.

SC2005_U-Maryland_Trials_1200.jpg
Pfizer/BioNTech have started dosing of their mRNA vaccines • Source: University of Maryland School of Medicine

More from COVID-19

More from Scrip